HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 479 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2023. The put-call ratio across all filers is 2.95 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $466,356 | +22267.2% | 4,273 | -76.7% | 0.02% | -78.7% |
| Q4 2022 | $2,085 | -99.8% | 18,323 | 0.0% | 0.08% | +70.5% |
| Q3 2022 | $1,134,000 | -69.7% | 18,323 | -60.9% | 0.04% | -67.6% |
| Q2 2022 | $3,740,000 | -20.8% | 46,893 | +4.5% | 0.14% | -6.8% |
| Q1 2022 | $4,721,000 | -0.9% | 44,872 | +1.5% | 0.15% | +4.3% |
| Q4 2021 | $4,765,000 | +30.3% | 44,223 | +32.4% | 0.14% | -6.7% |
| Q3 2021 | $3,658,000 | +106.4% | 33,399 | +76.6% | 0.15% | +105.5% |
| Q2 2021 | $1,772,000 | +51.5% | 18,917 | +48.8% | 0.07% | +43.1% |
| Q1 2021 | $1,170,000 | +23.2% | 12,717 | -2.0% | 0.05% | +18.6% |
| Q4 2020 | $950,000 | -20.5% | 12,983 | -15.6% | 0.04% | -29.5% |
| Q3 2020 | $1,195,000 | +62.8% | 15,385 | +16.6% | 0.06% | +56.4% |
| Q2 2020 | $734,000 | +47.7% | 13,200 | -21.3% | 0.04% | +30.0% |
| Q1 2020 | $497,000 | -18.1% | 16,770 | 0.0% | 0.03% | +3.4% |
| Q4 2019 | $607,000 | +32.8% | 16,770 | 0.0% | 0.03% | +20.8% |
| Q3 2019 | $457,000 | – | 16,770 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |